Selected research
Market Structure
Global Enteric-coated Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Enteric-coated Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enteric-coated Tablets include Boehringer Ingelheim, Dr. Reddy's Laboratories, Weidar Chemical & Pharmaceutical, AstraZeneca, Bayer, GSK, Novartis and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Enteric-coated Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enteric-coated Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enteric-coated Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enteric-coated Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Enteric-coated Tablets Segment by Company
Boehringer Ingelheim
Dr. Reddy's Laboratories
Weidar Chemical & Pharmaceutical
AstraZeneca
Bayer
GSK
Novartis
Takeda
Enteric-coated Tablets Segment by Type
Bisacodyl
Serrapeptase
Pantoprazole Sodium
Esomeprazole Magnesium
Aspirin
Enteric-coated Tablets Segment by Application
Hospital
Clinic
Enteric-coated Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enteric-coated Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enteric-coated Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enteric-coated Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Enteric-coated Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enteric-coated Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enteric-coated Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enteric-coated Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Bisacodyl
- Serrapeptase
- Pantoprazole Sodium
- Esomeprazole Magnesium
- Aspirin
Applications
- Hospital
- Clinic
Companies covered
- Boehringer Ingelheim
- Dr. Reddy's Laboratories
- Weidar Chemical & Pharmaceutical
- AstraZeneca
- Bayer
- GSK
- Novartis
- Takeda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enteric-coated Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enteric-coated Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Enteric-coated Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Enteric-coated Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Enteric-coated Tablets Market Dynamics
- 2.1 Enteric-coated Tablets Industry Trends
- 2.2 Enteric-coated Tablets Industry Drivers
- 2.3 Enteric-coated Tablets Industry Opportunities and Challenges
- 2.4 Enteric-coated Tablets Industry Restraints
3 Enteric-coated Tablets Market by Manufacturers
- 3.1 Global Enteric-coated Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Enteric-coated Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Enteric-coated Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Enteric-coated Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enteric-coated Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Enteric-coated Tablets Manufacturers, Product Type & Application
- 3.7 Global Enteric-coated Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enteric-coated Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enteric-coated Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Enteric-coated Tablets Tier 1, Tier 2, and Tier 3
4 Enteric-coated Tablets Market by Type
- 4.1 Enteric-coated Tablets Type Introduction
- 4.1.1 Bisacodyl
- 4.1.2 Serrapeptase
- 4.1.3 Pantoprazole Sodium
- 4.1.4 Esomeprazole Magnesium
- 4.1.5 Aspirin
- 4.2 Global Enteric-coated Tablets Sales by Type
- 4.2.1 Global Enteric-coated Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enteric-coated Tablets Sales by Type (2021-2032)
- 4.2.3 Global Enteric-coated Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Enteric-coated Tablets Revenue by Type
- 4.3.1 Global Enteric-coated Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Enteric-coated Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Enteric-coated Tablets Revenue Market Share by Type (2021-2032)
5 Enteric-coated Tablets Market by Application
- 5.1 Enteric-coated Tablets Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Enteric-coated Tablets Sales by Application
- 5.2.1 Global Enteric-coated Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enteric-coated Tablets Sales by Application (2021-2032)
- 5.2.3 Global Enteric-coated Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Enteric-coated Tablets Revenue by Application
- 5.3.1 Global Enteric-coated Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Enteric-coated Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Enteric-coated Tablets Revenue Market Share by Application (2021-2032)
6 Global Enteric-coated Tablets Sales by Region
- 6.1 Global Enteric-coated Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enteric-coated Tablets Sales by Region (2021-2032)
- 6.2.1 Global Enteric-coated Tablets Sales by Region (2021-2026)
- 6.2.2 Global Enteric-coated Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enteric-coated Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Enteric-coated Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Enteric-coated Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Enteric-coated Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Enteric-coated Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Enteric-coated Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Enteric-coated Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Enteric-coated Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Enteric-coated Tablets Revenue by Region
- 7.1 Global Enteric-coated Tablets Revenue by Region
- 7.1.1 Global Enteric-coated Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Enteric-coated Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Enteric-coated Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Enteric-coated Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Enteric-coated Tablets Revenue (2021-2032)
- 7.2.2 North America Enteric-coated Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Enteric-coated Tablets Revenue (2021-2032)
- 7.3.2 Europe Enteric-coated Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Enteric-coated Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Enteric-coated Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Enteric-coated Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Enteric-coated Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Company Information
- 8.1.2 Boehringer Ingelheim Business Overview
- 8.1.3 Boehringer Ingelheim Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Boehringer Ingelheim Enteric-coated Tablets Product Portfolio
- 8.1.5 Boehringer Ingelheim Recent Developments
- 8.2 Dr. Reddy's Laboratories
- 8.2.1 Dr. Reddy's Laboratories Company Information
- 8.2.2 Dr. Reddy's Laboratories Business Overview
- 8.2.3 Dr. Reddy's Laboratories Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Dr. Reddy's Laboratories Enteric-coated Tablets Product Portfolio
- 8.2.5 Dr. Reddy's Laboratories Recent Developments
- 8.3 Weidar Chemical & Pharmaceutical
- 8.3.1 Weidar Chemical & Pharmaceutical Company Information
- 8.3.2 Weidar Chemical & Pharmaceutical Business Overview
- 8.3.3 Weidar Chemical & Pharmaceutical Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Weidar Chemical & Pharmaceutical Enteric-coated Tablets Product Portfolio
- 8.3.5 Weidar Chemical & Pharmaceutical Recent Developments
- 8.4 AstraZeneca
- 8.4.1 AstraZeneca Company Information
- 8.4.2 AstraZeneca Business Overview
- 8.4.3 AstraZeneca Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 AstraZeneca Enteric-coated Tablets Product Portfolio
- 8.4.5 AstraZeneca Recent Developments
- 8.5 Bayer
- 8.5.1 Bayer Company Information
- 8.5.2 Bayer Business Overview
- 8.5.3 Bayer Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bayer Enteric-coated Tablets Product Portfolio
- 8.5.5 Bayer Recent Developments
- 8.6 GSK
- 8.6.1 GSK Company Information
- 8.6.2 GSK Business Overview
- 8.6.3 GSK Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GSK Enteric-coated Tablets Product Portfolio
- 8.6.5 GSK Recent Developments
- 8.7 Novartis
- 8.7.1 Novartis Company Information
- 8.7.2 Novartis Business Overview
- 8.7.3 Novartis Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Novartis Enteric-coated Tablets Product Portfolio
- 8.7.5 Novartis Recent Developments
- 8.8 Takeda
- 8.8.1 Takeda Company Information
- 8.8.2 Takeda Business Overview
- 8.8.3 Takeda Enteric-coated Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Takeda Enteric-coated Tablets Product Portfolio
- 8.8.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Enteric-coated Tablets Value Chain Analysis
- 9.1.1 Enteric-coated Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Enteric-coated Tablets Production Mode & Process
- 9.2 Enteric-coated Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Enteric-coated Tablets Distributors
- 9.2.3 Enteric-coated Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst